Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-195,489
| Closed | -$3.52M | – | 74 |
|
|
2020
Q1 | $3.52M | Sell |
195,489
-28,001
| -13% | -$504K | 1.29% | 32 |
|
|
2019
Q4 | $5.3M | Sell |
223,490
-8,540
| -4% | -$203K | 1.35% | 33 |
|
|
2019
Q3 | $6.38M | Buy |
232,030
+41,740
| +22% | +$1.15M | 1.75% | 30 |
|
|
2019
Q2 | $6.3M | Buy |
190,290
+18,420
| +11% | +$610K | 1.74% | 30 |
|
|
2019
Q1 | $6.02M | Sell |
171,870
-102,587
| -37% | -$3.59M | 1.65% | 29 |
|
|
2018
Q4 | $9.12M | Buy |
274,457
+49,225
| +22% | +$1.64M | 2.83% | 12 |
|
|
2018
Q3 | $11.3M | Buy |
225,232
+118,152
| +110% | +$5.95M | 2.9% | 10 |
|
|
2018
Q2 | $6.41M | Sell |
107,080
-32,455
| -23% | -$1.94M | 1.72% | 31 |
|
|
2018
Q1 | $6.39M | Buy |
139,535
+4,715
| +3% | +$216K | 1.72% | 29 |
|
|
2017
Q4 | $5.37M | Buy |
134,820
+23,220
| +21% | +$925K | 1.46% | 33 |
|
|
2017
Q3 | $4.46M | Sell |
111,600
-5,400
| -5% | -$216K | 1.27% | 34 |
|
|
2017
Q2 | $5.04M | Sell |
117,000
-4,660
| -4% | -$201K | 1.51% | 33 |
|
|
2017
Q1 | $3.81M | Buy |
121,660
+220
| +0.2% | +$6.89K | 1.18% | 34 |
|
|
2016
Q4 | $3.07M | Buy |
121,440
+57,645
| +90% | +$1.46M | 1.02% | 39 |
|
|
2016
Q3 | $1.58M | Buy |
63,795
+28,165
| +79% | +$697K | 0.58% | 42 |
|
|
2016
Q2 | $726K | Buy |
+35,630
| New | +$726K | 0.28% | 54 |
|